GOSS EBITDA Growth
Gossamer Bio Inc · EBITDA Growth
GOSS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-59.03%period ending
GOSS TTM EBITDA YoY % (-2060.53% → -59.03%)
Year-over-year change
High-resolution chart · PNG
GOSS ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -59.035% | |
| -372.1992% | |
| -296.4946% | |
| -178.9698% | |
| -115.3371% | |
| 76.9962% | |
| 75.317% | |
| 69.1233% | |
| 68.3031% | |
| 23.3055% | |
| 23.2853% | |
| 19.4084% | |
| 9.9481% | |
| 4.1027% | |
| -0.7985% | |
| 9.9012% | |
| 9.3903% | |
| 12.2857% | |
| 13.2838% | |
| -6.1565% | |
| -6.2465% | |
| -21.3723% | |
| -35.2038% | |
| -32.6076% | |
| -38.0398% | |
| -57.7639% | |
| -50.3% | |
| -93.2137% | |
| -257.5224% | |
| -298.484% | |
| -2,060.5273% |